65th ASH Annual Meeting & Exposition: 901. Health Services and Quality Improvement – Non-Malignant Conditions: Raising the bar in Anemia, Bleeding, and Thrombotic Disorders

Symposia: Health Services and Quality Improvement - Non-Malignant Conditions Oral and Poster Abstracts
Oral

Bleeding and Clotting, bleeding disorders, Sickle Cell Disease, Clinical Practice (Health Services and Quality), hemophilia, Hemoglobinopathies, Diseases, Maternal Health

Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)

Moderators:

Jason A Freed, MD, Beth Israel Deaconess and Prarthana Parthasarathy, MD, Riley Hospital for Children at Indiana University

Disclosures:

No relevant conflicts of interest to declare.

A plethora of hematology care. From use of IV iron, to inherited bleeding disorders, menstrual bleeding in SCD, and thrombosis management in cancer patients.

4:30 PM

661

Comparison of Khorana Vs. Onkotev Predictive Score to Individualize Anticoagulant Prophylaxis in Ambulatory Patients with Cancer

Chiara Alessandra Cella, MD, PhD¹^*, Nicola Fazio¹^*, Florian Lordick²^*, Vincenzo Bagnardi^3,4^*, Samuele Frassoni⁴^*, Lorenzo Gervaso^1,5^*, Carmine Valenza⁶^*, Iztok Hozo, PhD⁷^* and Benjamin Djulbegovic, MD⁸

¹Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milano, Italy
²University Cancer Center Leipzig (UCCL), University Hospital Leipzig, Leipzig, Germany, Leipzig, Germany
³European Institute of Oncology, Milan, ITA
⁴Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milano, Italy
⁵Molecular Medicine Department, University of Pavia, Pavia, Italy, Pavia, Italy
⁶Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milano, Italy
⁷Indiana University Northwest, Gary
⁸Medical University of South Carolina, Charleston, SC

4:45 PM

662

Developing an Algorithm to Better Identify Pregnant Women with Inherited Bleeding Disorders within Electronic Health Records

Ming Y Lim, MBBChir¹, Vasee Sivaloganathan²^* and Sara E Simonsen²^*

¹Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT
²University of Utah, Salt Lake City

5:00 PM

663

Physical Activity, Bleedings and Quality of Life in Patients with Haemophilia a without Inhibitors - a Multicenter, Observational Italian Study with a Wearable Device

MariaElisa Mancuso, MD¹^*, Chiara Biasoli, MD²^*, Renato Marino, MD³^*, Andrea Buzzi⁴^*, Daniele Preti⁵^*, Sara Bendinelli, PhD⁶^*, Rosaria Tempre, MSc⁶^*, Elena Pompeo⁶^*, Luigi Sannino, MSc⁶^*, Giacomo Siri, PhD⁷^* and Giancarlo Castaman, MD⁸^*

¹Centre for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Italy
²Centro Emofilia - U.O.C. Medicina Trasfusionale - Dipartimento Patologia, Clinica Ospedale M. Bufalini, Cesena, Italy
³S.S.D. Centro Emofilia e Trombosi, Ospedale Policlinico, Bari, ITA
⁴Fondazione Paracelso, milano, Italy
⁵Federazione Associazioni Emofilici, Milano, Italy
⁶Roche S.p.a, Monza, Italy
⁷Alira Health S.r.l., Milano, Italy
⁸SOD Malattie Emorragiche, AOU Careggi, Firenze, Italy

5:15 PM

664

Characteristics Associated with the Success of Immune Tolerance Induction Among People with Severe Hemophilia a in the United States

Stacey Fedewa, PhD, MPH¹^*, Amanda B. Payne, PhD, MPH², Lorraine Cafuir, MD³, Duc Quang Tran, MD, MSc³, Ana G. Antun, MD⁴ and Christine Kempton, MD³

¹Department of Hematology and Medical Oncology and Hemophilia of Georgia Center for Bleeding & Clotting Disorders at Emory, Emory University, Atlanta, GA
²Centers For Disease Control and Prevention, Atlanta, GA
³Emory University, Atlanta, GA
⁴Emory University, Decatur, GA

5:30 PM

665

Role of Menstrual Bleeding Assessments in Sickle Cell Clinics in Improving Quality of Care for Women- a Multicenter Approach

Neha Bhasin, MD^1,2,3, Gillian Rush, CRC¹^*, John J Strouse, MD, PhD^4,5, Kim Moffatt-Bazile, NP^3,6^*, Rania E Mohamed, CRC⁴^*, Seethal A Jacob, MD, MS^7,8, Bindu Kanathezhath Sathi, MD^3,9, Gayle M Smink, MD, MPH^8,10, Corinna L. Schultz, MD¹¹, Nicole DiVirgilio, CRC¹²^*, Elliott P. Vichinsky, MD^1,13, Maria C Velez, MD^8,14^*, Robert Hagar, MD^3,15, Maa-Ohui Quarmyne, MD, MS¹⁶, Ugochi Ogu, MD¹⁷^* and Marsha Treadwell, PhD^1,3,8

¹Department of Pediatrics, Division of Hematology, University of California San Francisco Benioff Children's Hospital, Oakland, CA
²FWGBD, WGSCD Learning Action Network Clinical Care Subcommittee, Montclair, NJ
³Pacific Sickle Cell Regional Collaborative (PSCRC), Oakland, CA
⁴Department of Medicine, Division of Hematology, Duke University School of Medicine, Durham, NC
⁵FWGBD, WGSCD Learning Action Network’s Clinical Care Subcommittee, Montclair, CA
⁶Children's Hospital Oakland, Oakland, CA
⁷Department of Pediatrics, Division of Hematology Oncology, Riley Hospital for Children, Indianapolis, IL
⁸FWGBD, WGSCD Learning Action Network’s Clinical Care Subcommittee, Montclair, NJ
⁹Hematology/Oncology, Valley Children's Hospital, Madera, CA
¹⁰Department of Pediatrics, Division of Hematology Oncology, Penn State University, Hershey, PA
¹¹Center for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, DE
¹²Center for Cancer and Blood Disorders, Nemours Children’s Health, Wilmington, DE
¹³Pacific Sickle Cell Regional Collaborative (PSCRC), Oakland
¹⁴Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital New Orleans, Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA
¹⁵Department of Pediatrics, Division of Hematology, University of California San Francisco Benioff Children's Hospitals, Oakland, CA
¹⁶Center of Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ
¹⁷Division of Hematology/Oncology, University of Tennessee Health Science Center Center for Sickle Cell Disease, Memphis, TN

5:45 PM

666

Contemporary Intravenous Iron Usage and Safety Patterns

Richard C. Godby, MD, Sarah A. Chase^*, Ronald S. Go, MD and Chelsee J. Jensen^*

Mayo Clinic, Rochester, MN

See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

901.O2.6 901. Health Services and Quality Improvement – Non-Malignant Conditions: Raising the bar in Anemia, Bleeding, and Thrombotic Disorders